Arbutus Biopharma Corp. buy melinda
Start price
16.10.18
/
50%
€4.19
Target price
02.11.18
€6.31
Performance (%)
13.55%
End price
02.11.18
€4.76
Summary
This prediction ended on 02.11.18 with a price of €4.76. The prediction had a final performance of 13.55%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arbutus Biopharma Corp. | -1.963% | -1.963% | 23.257% | 55.729% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
According to melinda what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
SecteurProduits pharmaceutiques Agenda 08/11 Publication de résultats
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection.
The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.
Nombre d'employés : 130 personnes.
Stopped prediction by melinda for Arbutus Biopharma Corp.
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.20
24.12.23
24.12.23
-
24.12.24
24.12.24
1.36%
06.01.24
06.01.24
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.03
08.07.23
08.07.23
-
08.07.24
08.07.24
-18.91%
26.11.23
26.11.23
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.08
20.05.20
20.05.20
€4.50
04.11.21
04.11.21
56.99%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.14
06.01.20
06.01.20
-
20.05.20
20.05.20
-33.64%
20.05.20
20.05.20
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.73
03.06.19
03.06.19
€2.35
20.06.19
20.06.19
36.98%
20.06.19
20.06.19
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€6.55
21.10.17
21.10.17
€7.50
27.12.17
27.12.17
-26.72%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€5.91
21.10.17
21.10.17
€6.77
27.12.17
27.12.17
-26.72%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year